Sumitomo Mitsui Trust Group Inc. Has $186.12 Million Stake in Ventas, Inc. $VTR

Sumitomo Mitsui Trust Group Inc. lowered its position in shares of Ventas, Inc. (NYSE:VTR) by 9.3% during the first quarter, HoldingsChannel reports. The fund owned 2,275,887 shares of the real estate investment trust’s stock after selling 234,579 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in Ventas were worth $186,122,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of VTR. Bridgewater Advisors Inc. raised its position in Ventas by 2.0% in the fourth quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock valued at $525,000 after purchasing an additional 133 shares during the last quarter. IHT Wealth Management LLC grew its holdings in shares of Ventas by 3.2% during the fourth quarter. IHT Wealth Management LLC now owns 4,415 shares of the real estate investment trust’s stock worth $343,000 after purchasing an additional 137 shares during the last quarter. True Wealth Design LLC grew its holdings in shares of Ventas by 32.0% during the fourth quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock worth $44,000 after purchasing an additional 138 shares during the last quarter. Cigna Investments Inc. New increased its stake in shares of Ventas by 3.3% in the fourth quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock valued at $341,000 after buying an additional 142 shares during the period. Finally, Parallel Advisors LLC increased its stake in shares of Ventas by 4.6% in the third quarter. Parallel Advisors LLC now owns 3,970 shares of the real estate investment trust’s stock valued at $278,000 after buying an additional 175 shares during the period. Institutional investors and hedge funds own 94.18% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on VTR. Mizuho set a $98.00 target price on shares of Ventas in a research report on Friday, May 22nd. Scotiabank dropped their price target on shares of Ventas from $95.00 to $88.00 and set a “sector perform” rating for the company in a research note on Thursday, June 18th. Raymond James Financial began coverage on shares of Ventas in a report on Tuesday, June 16th. They set an “outperform” rating and a $94.00 price target on the stock. Wells Fargo & Company boosted their price objective on shares of Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a research note on Monday, June 1st. Finally, Jefferies Financial Group increased their price objective on Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, May 12th. Fifteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $96.17.

Ventas Stock Performance

Shares of VTR opened at $91.80 on Friday. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. The firm’s fifty day simple moving average is $86.54 and its two-hundred day simple moving average is $83.61. Ventas, Inc. has a 12 month low of $62.47 and a 12 month high of $94.60. The stock has a market capitalization of $44.63 billion, a P/E ratio of 166.91, a price-to-earnings-growth ratio of 1.99 and a beta of 0.70.

Ventas (NYSE:VTR) last posted its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same period last year, the business posted $0.84 earnings per share. The business’s revenue was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, analysts predict that Ventas, Inc. will post 3.88 EPS for the current year.

Ventas Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.52 per share. The ex-dividend date is Tuesday, June 30th. This represents a $2.08 annualized dividend and a dividend yield of 2.3%. Ventas’s dividend payout ratio is currently 378.18%.

Insider Transactions at Ventas

In other news, Director Michael J. Embler purchased 2,500 shares of the company’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were acquired at an average cost of $78.81 per share, with a total value of $197,025.00. Following the purchase, the director owned 19,202 shares in the company, valued at $1,513,309.62. This represents a 14.97% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Walter C. Rakowich sold 1,152 shares of the company’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total value of $103,910.40. Following the transaction, the director directly owned 28,349 shares in the company, valued at $2,557,079.80. The trade was a 3.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.53% of the company’s stock.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.